SCHEMBL96092

SCHEMBL96092

NC(=O)CCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,4-Butanediol SCHEMBL28624681 1.00 GPR84 (0.55)
SCHEMBL2011125 0.97 GPR84 (0.60)
SCHEMBL95430 0.97 GPR84 (0.60)
SCHEMBL1479946 0.97 GPR84 (0.60)
SCHEMBL2839590 0.97 GPR84 (0.60)
SCHEMBL7554526 0.97 GPR84 (0.60)
SCHEMBL5575807 0.97 GPR84 (0.60)
SCHEMBL5575804 0.97 GPR84 (0.60)
SCHEMBL8411317 0.97 GPR84 (0.60)
SCHEMBL28624684 0.97 GPR84 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 514 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118878440-A Method for synthesizing bio-based glutaronitrile from furfural 河北工业大学 2024-11-01 CN claimed
CN-118240193-A Preparation method of recyclable N-acylated polyaminoester 苏州大学 2024-06-25 CN claimed
WO-2023221188-A1 POLYESTER BASE FILM AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, ELECTRODE SHEET, AND LITHIUM BATTERY CELL 扬州纳力新材料科技有限公司 2023-11-23 WO claimed
EP-4031162-A1 KV1.3 BLOCKERS Zealand Pharma A/S (DK) 2022-07-27 EP claimed
EP-2702038-A1 SYNTHESIS OF HYDROXYALKYL AMIDES FROM ESTERS Johnson & Johnson Vision Care Inc. (US) 2014-03-05 EP claimed
CN-103492360-A Synthesis of hydroxyalkyl amides from esters JOHNSON & JOHNSON VISION CRAE INC 2014-01-01 CN claimed
WO-2012148624-A1 SYNTHESIS OF HYDROXYALKYL AMIDES FROM ESTERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2012-11-01 WO claimed
US-20120277444-A1 SYNTHESIS OF HYDROXYALKYL AMIDES FROM ESTERS JOHNSON & JOHNSON VISION CARE, INC. 2012-11-01 US claimed
JP-2011529955-A 2011-12-15 JP claimed
EP-2324028-A2 THERAPEUTIC AGENTS 414 AstraZeneca AB (SE) 2011-05-25 EP claimed
WO-2005118572-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES ASTRAZENECA AB (SE) 2005-12-15 WO claimed
EP-1551809-A1 PYRAZOLE COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Inc. (US) 2005-07-13 EP claimed
WO-2005058309-A1 NOVEL THERAPEUTIC USE OF INDOLINONE DERIVATIVES LEO PHARMA A/S (DK) 2005-06-30 WO claimed
US-20040259887-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC 2004-12-23 US claimed
US-6797820-B2 HYDROXAMATE DERIVATIVES THAT INHIBIT PEPTIDYL DEFORMYLASE (PDF), ANTIMICROBIALS AND ANTIBIOTICS VICURON PHARMACEUTICALS INC. 2004-09-28 US claimed
US-20040142997-A1 Pyrazole compounds for treatment of neurodegenerative disorders PFIZER INC. 2004-07-22 US claimed
WO-2004033434-A1 PYRAZOLE COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS INC. (US) 2004-04-22 WO claimed
EP-1237862-A1 SUCCINATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE AND PREPARATION Versicor, Inc. (US) 2002-09-11 EP claimed
US-20020115863-A1 Novel succinate compounds, compositions and methods of use and preparation VICURON HOLDINGS LLC 2002-08-22 US claimed
WO-2001044179-A1 NOVEL SUCCINATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE AND PREPARATION VERSICOR, INC. (US) 2001-06-21 WO claimed